Tumor immunity and the mechanism of polyinosinic-polycytidylic acid inhibition of tumor growth.
D000230:Adenocarcinoma / Q000188:drug therapy / Q000276:immunology*; D000818:Animals; D000917:Antibody Formation; D000961:Antilymphocyte Serum; D005260:Female; D006736:Horses / Q000276:immunology; D007111:Immunity, Cellular; D007165:Immunosuppression Therapy; D008214:Lymphocytes / Q000276:immunology; D008297:Male; D008325:Mammary Neoplasms, Experimental / Q000188:drug therapy / Q000276:immunology*; D008545:Melanoma / Q000188:drug therapy / Q000276:immunology*; D051379:Mice; D008815:Mice, Inbred Strains; D009368:Neoplasm Transplantation; D011070:Poly I-C / Q000494:pharmacology* / Q000627:therapeutic use; D011828:Radiation Chimera; D051381:Rats; D011919:Rats, Inbred Strains; D016038:Skin Transplantation; D014184:Transplantation, Homologous
D000961:Antilymphocyte Serum; D011070:Poly I-C